X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer is a deputy vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Silver Spring, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Recent Posts

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 1, 2016
Discriminatory effect of insurance plan structure – New research from Harvard’s Center for Health Law and Policy Innovation (CHLPI) shows evidence that some insurance plans are designed to...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    March 25, 2016
FDA quality metrics:  Building on our constructive ideas for improvements to the FDA’s recent proposal for a mandatory metrics program, we featured a guest blog post from Mairead Goetz, head of...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

What “value” means to me

By Priscilla VanderVeer  |    March 17, 2016
It’s March, which means it is National Kidney Month. More than 661,000 Americans have kidney failure. Every day, approximately 13 people die waiting for a kidney transplant. I am lucky to not be...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 4, 2016
Communications with health care professionals – A new paper from the Duke-Margolis Center for Health Policy rightly makes the argument in favor of establishing a more effective regulatory...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    February 26, 2016
Fighting abuse in Massachusetts: PhRMA was joined by Massachusetts Governor Charlie Baker and President of the Massachusetts Chiefs of Police Association at an event in Boston this week to discuss...   Read More

MyOldMeds campaign launches in Massachusetts

By Priscilla VanderVeer  |    February 25, 2016
Every day in Massachusetts, four people die from an opioid overdose. It is one of the most difficult public health challenges facing the Commonwealth, and the country. Prescription drug abuse...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    February 19, 2016
Coverage does not equal access: While the burden of high deductibles has already received significant attention, new data reveals that consumers have no choice but to pay up to thousands of...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    February 12, 2016
Today’s “Week in Review” covers the last two weeks of activity here at PhRMA. As you’ll see, we’ve been busy! We’re Fighting Back: Our new From Hope to Cures ad campaign launched on Monday. In it,...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    January 29, 2016
Record number of new medicines in 2015: The FDA’s Center for Drug Evaluation and Research’s (CDER) fifth annual Novel New Drugs Summary approved a record 45 new medicines in 2015, marking the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates